Brand system · v0.1 · workshop view
This page exposes the workshop behind the brand system: every candidate name, every logo variant, every palette token, every tagline under consideration. It is the decision-aid the KFSHRC Program Office, BOD, and Royal Court advisors use to review the identity work before Phase B locks the system. Nahda Cellworks (نهضة) is the recommended primary — a modern Saudi-civic name that encodes biotech sovereignty as a chapter of the national renaissance opened by King Faisal's modernization and carried forward by Vision 2030. The biotech-vocabulary backstops (Nawah, Tahdith, Riyadh) are documented here so the recommendation can be tested against them.
01 · Name candidates
The 28 May BOD slate tested heritage-figure names (Hayyan, Razi, Avicenna) against generic identity criteria. Re-scoring against KFSH-fit — Saudi anchor + Academic-Hybrid CDMO register + bilingual ownability + religious/geopolitical-neutrality — surfaces a stronger anchor: a modern Saudi-civic concept (نهضة / nahda) rather than a historical figure rooted outside the Kingdom. The biotech-vocabulary backstops (Nawah, Tahdith, Riyadh) test the recommendation from three different angles.
Anchor: Nahda (نهضة) means "renaissance / awakening" — names the Saudi national renewal opened by King Faisal's modernization programme and carried forward by Vision 2030. No historical-figure baggage, no religious resonance, no geopolitical heritage anchors. "Cellworks" matches the CDMO function. Modern Saudi-civic register.
"Nawah" (نواة) = "nucleus / seed". Direct ATMP vocabulary: the cell nucleus is the locus of gene therapy; the seed is the source of regenerative biology. Dual-meaning encodes both halves of the CGT universe in one word. Biotech-precise, secular, no historical baggage.
Geographic anchor: the city of Riyadh (الرياض, "the gardens"). Playbook: the same naming logic as Boston Scientific, London Stem Cells, Cambridge Bioscience — claiming the city as the institutional anchor. Visual mark uses the Najdi triangular pointed-arch lattice (Diriyah, Riyadh Metro register). Direct, unambiguous, secular.
"Tahdith" (تحديث) = "modernization / renewal / making-new" — the verb-form of nahda. References the King Faisal-era Saudi modernization programme (1960s–70s) and Vision 2030's modernization framing. Visual: ascending bars (graduated progress). Secular, modernist-civic, no religious resonance.
Including the original BOD slate (28 May), the four primary candidates, and excluded candidates with reasons.
| # | Candidate | Heritage | Mfg | Intl | Own | Biling | Co-brand | Acad | Score | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nahda Cellworks | 5 | 5 | 5 | 4 | 5 | 5 | 4 | 4.70 | Recommend |
| 2 | Nawah Cellworks | 5 | 5 | 4 | 5 | 5 | 4 | 4 | 4.20 | Backstop |
| 3 | Riyadh Cellworks | 5 | 5 | 4 | 3 | 4 | 5 | 4 | 4.10 | Backstop |
| 4 | Tahdith Cellworks | 4 | 5 | 3 | 4 | 4 | 4 | 5 | 4.05 | Backstop |
| 5 | Hayyan Cellworks (28-May lead) | 5 | 5 | 4 | 4 | 5 | 5 | 5 | 4.55 | Iraqi-Persian anchor |
| 6 | Najmah Cellworks | 3 | 5 | 4 | 5 | 4 | 4 | 3 | 4.05 | Religious anchor |
| 7 | Al-Kindi Bio | 5 | 3 | 3 | 5 | 4 | 4 | 5 | 4.00 | Iraqi-figure anchor |
| 8 | Sayyad Cell & Gene | 3 | 5 | 5 | 4 | 4 | 4 | 3 | 3.95 | Provisional Arabic |
| 9 | Hayyan Biomanufacturing | 5 | 5 | 4 | 4 | 4 | 5 | 5 | 4.45 | Iraqi-Persian anchor |
| 10 | Hayyan Therapeutics | 5 | 2 | 4 | 4 | 5 | 5 | 4 | 3.85 | Therapeutics vs. CDMO |
| 11 | Najmah Bioworks | 3 | 4 | 4 | 5 | 4 | 4 | 3 | 3.85 | Alt |
| 12 | Sanad Cellworks | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3.75 | Alt |
| 13 | Bayan Therapeutics | 3 | 2 | 4 | 4 | 4 | 4 | 3 | 3.30 | Suffix mismatch |
03 · Colour palette
Mirrors KFSHRC's institutional green-and-gold register rather than competing with it. Builds parent-institution affinity. Navy is preserved as the typographic ink layer so the register stays serious.
04 · Typography
Mirrors KFSH's live web register exactly. KFSH's proprietary KFSH typeface is unavailable externally; their fallback is Noto Sans / Noto Sans Arabic, which we adopt as the digital standard for the affiliate. Cormorant Garamond + Amiri remain candidates for editorial print collateral.
05 · Tagline candidates
Phase B narrows to one. Each candidate is a different angle on the same brand: heritage anchor, geographic anchor, methodology anchor, mission anchor. The recommended primary is the first; alternates exist so the choice can be tested rather than assumed.
06 · Voice register
Reserved · evidence-led · third-person. The reference register is institutional teaching-hospital, not biotech startup. Vision 2030 alignment lives in the brand story, never in the slogan.
Voice and tone calibrated against:
Explicitly NOT calibrated against: Moderna, Vertex, Vor Bio, Arcus, or any biotech IPO-style messaging.
Trademark agent preference · Royal Court naming constraints · KFSHRC co-branding rules · Legal vs. trade-name structure · Vision 2030 endorsement framework. Surfaced for the Phase A kickoff brief.
← Return to the live brand